Orbimed Advisors LLC Celldex Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $1.33 Million - $2.39 Million	58,800 New	58,800 $2.33 Million
Q2 2022 Aug 15, 2022	SELL	$20.5 - $37.33 $6.01 Million - $11 Million	-293,400 Reduced 72.25%	112,700 $3.04 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $292,576 - $461,414	-8,200 Reduced 1.98%	406,100 $15.7 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $12 Million - $23.2 Million	414,300 New	414,300 $22.4 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $9.37 Million - $14.2 Million	-625,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $1.01 Million - $8.38 Million	625,000 New	625,000 $8.13 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.